Standard BioTools Stock (NASDAQ:LAB), Quotes and News Summary

Q: What sector and industry does Standard BioTools (LAB) operate in?

Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Standard BioTools Stock (NASDAQ: LAB) stock price, news, charts, stock research, profile.

Open	$2.350
Close	-
Volume / Avg.	858.598K / 2.103M
Day Range	2.310 - 2.400
52 Wk Range	1.460 - 3.160
Market Cap	$908.345M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	2.8%
Days to Cover	5.8

Recent News

Quantum-Si And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed higher by around 75 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Standard BioTools Get a Buy Rating, Analyst Cites Unique Technology, Management and Board

KeyBanc Capital Markets initiated coverage on Standard BioTools Inc (NASDAQ: LAB) with an Overweight rating and a

Vandana Singh

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Standard BioTools Inc

Sector

Health Care

Industry

Life Sciences Tools & Services

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researcher...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Standard BioTools (LAB) stock?

You can purchase shares of Standard BioTools (NASDAQ: LAB) through any online brokerage.

View our list of the best stock brokerages.

Who are Standard BioTools's (LAB) competitors?

Other companies in Standard BioTools’s space includes: 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS), Quanterix (NASDAQ:QTRX), Sotera Health (NASDAQ:SHC) and Olink Holding (NASDAQ:OLK).

What is the target price for Standard BioTools (LAB) stock?

The latest price target for Standard BioTools (NASDAQ: LAB) was reported by TD Cowen on Tuesday, April 16, 2024. The analyst firm set a price target for 3.50 expecting LAB to rise to within 12 months (a possible 55.56% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Standard BioTools (LAB)?

The stock price for Standard BioTools (NASDAQ: LAB) is $2.25 last updated April 25, 2024 at 4:50 PM EDT.

Does Standard BioTools (LAB) pay a dividend?

There are no upcoming dividends for Standard BioTools.

When is Standard BioTools (NASDAQ:LAB) reporting earnings?

Standard BioTools’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is Standard BioTools (LAB) going to split?

There is no upcoming split for Standard BioTools.

What sector and industry does Standard BioTools (LAB) operate in?

Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-